| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |